T

Touchstone International Medical Science Co Ltd
SSE:688013

Watchlist Manager
Touchstone International Medical Science Co Ltd
SSE:688013
Watchlist
Price: 36.21 CNY -2.71% Market Closed
Market Cap: ¥2.9B

EV/GP

15.3
Current
55%
More Expensive
vs 3-y average of 9.9

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
15.3
=
Enterprise Value
¥3.5B
/
Gross Profit
¥192.8m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
15.3
=
Enterprise Value
¥3.5B
/
Gross Profit
¥192.8m

Valuation Scenarios

Touchstone International Medical Science Co Ltd is trading above its 3-year average

If EV/GP returns to its 3-Year Average (9.9), the stock would be worth ¥23.44 (35% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-45%
Maximum Upside
No Upside Scenarios
Average Downside
32%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 15.3 ¥36.21
0%
3-Year Average 9.9 ¥23.44
-35%
5-Year Average 9.7 ¥22.87
-37%
Industry Average 8.4 ¥19.84
-45%
Country Average 13.6 ¥32.07
-11%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close

Market Distribution

In line with most companies in China
Percentile
55th
Based on 6 967 companies
55th percentile
15.3
Low
0 — 8
Typical Range
8 — 23.3
High
23.3 —
Distribution Statistics
China
Min 0
30th Percentile 8
Median 13.6
70th Percentile 23.3
Max 17 898 541.1

Touchstone International Medical Science Co Ltd
Glance View

Market Cap
2.9B CNY
Industry
Health Care

Touchstone International Medical Science Co., Ltd. specializes in the development of advanced and innovative surgical devices that enhance clinical performance, mini-mize risk, and improve patient outcomes. The company is headquartered in Suzhou, Jiangsu and currently employs 206 full-time employees. The company went IPO on 2020-09-28. The firm's products include tubular staplers, endoscopic staplers, linear cutting staplers, purse-string staplers and linear suture staplers. Its products are used in the surgical fields of cardiothoracic surgery, gastrointestinal surgery, hepatobiliary spleen and pancreatic surgery, general surgery and urology. The firm conducts its businesses within the China market and to overseas markets such as Italy, Spain, Austria, Brazil, South Korea, the United Kingdom and Australia.

Intrinsic Value
18.45 CNY
Overvaluation 49%
Intrinsic Value
Price ¥36.21
T
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett